Keywords: roche, fuzeon, shows, reduced, toxicity, new, 48-week

Roche's Fuzeon shows reduced toxicity

Article | 23 February 2004

Print This

A new 48-week analysis of the TORO 1 and 2 trials for Roche's Fuzeon (enfuvirtide) has revealed that the agent had no ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in